Identification of 5 TP53 mutations in oral rinses from healthy controls confirms the presence of a small percentage of pathogenic mutations in healthy individuals, a fact that should be taken into consideration when developing diagnostic ctDNA assays for early HNSCC detection. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.